30 cases of second renal transplants

European Urology
L PotauxM le Guillou

Abstract

30 second renal transplants from cadaver donors were performed. 93% of patients survived for 1 year and 89% for 2 years. 66% of grafts survived for 2 year and 57% for 2 years. Best results can be expected with patients less than 40 years old whose first transplant failed through chronic rejection, whether or not cytotoxic antibodies were present. The best histocompatibility in the HLA A and B system should be sought.

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.